Skip to content

The Effect of Energy Drink on Cardiovascular Variables: A Randomized Controlled Trial

The Effect of Energy Drink on Cardiovascular Variables: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03841838
Enrollment
20
Registered
2019-02-15
Start date
2019-02-23
Completion date
2019-05-09
Last updated
2019-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases

Keywords

Energy drink, Heart rhythm, QT prolongation, Blood pressure

Brief summary

Many adults in the United States regularly consumer energy drinks. Currently, the safety of energy drinks is still questionable and there are many reports associating energy drinks with adverse events including hospitalizations and deaths. Previous research shows that energy drink can affect heart rhythm and elevate blood pressure. However, these studies use a higher volume (32 ounces) of energy drinks than those available in the market (24 ounces). The purpose of this study is to study if 24-ounce energy drinks can significantly affect heart rhythm and elevate blood pressure when compared to a placebo.

Detailed description

The study is a randomized, double blind, controlled, crossover study comparing the effect of energy drinks and placebo on cardiovascular parameters including heart rhythm and blood pressure. Subjects who contact the PI for interest in study participation will be scheduled a time to study facility for initial evaluation on eligibility criteria. At initial evaluation, participants will be informed about the study details, presented with Informed Consent Document (ICD), and be asked to sign the appropriate forms voluntarily if they decide to participate. Once consented, participants will be asked a series of questions and screened for blood pressure and heart rhythm parameters to determine eligibility to enroll. If patient is eligible to enroll, they will be allocated a randomized identification number. Participants will be randomly assigned to consume either two-12 oz bottles of energy drink and two-12 oz bottles of control drink on 2 separate days. The study will occur over approximately 8 days with each session taking about 5 hours per day. Each session will have 6 days between each other. Participants will be expected to refrain from any products containing caffeine or alcohol 48 hours and fast 10 hours before each study visit. At the beginning of each study visit, baseline measurements of ECG, blood pressures, and heart rate will be obtained prior to consuming study drinks. Repeat measurements will be obtained every 60 minutes after consumption over 4 hours.

Interventions

Two 12 oz bottles of commercially available energy drink

OTHERPlacebo drink

Two 12 oz bottles placebo drink. Placebo drink will contain carbonated water, lime juice, and cherry flavoring.

Sponsors

University of the Pacific
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy male or female adults 18-40 years old * Participants must be willing to refrain from caffeine and alcohol use 48 hours prior to each study day * Participants must be willing to fast 10 hours prior to each study day * Participants must have health insurance

Exclusion criteria

* Corrected QT (QTc) interval greater than 450 milliseconds (ms). QTc will be determined on the ECG obtained during initial screening appointment. * Blood pressure at initial screening appointment greater than 140/90 mmHg. * Presence of any known medical condition confirmed through participant interview * Concurrent use of ANY medication taken on a daily basis, to include herbal products or supplements (exception include oral contraceptives that will be allowed if taking for longer than 1 month) * Current smokers or those who have smoked any cigarettes within the past month * Pregnant or currently breastfeeding

Design outcomes

Primary

MeasureTime frameDescription
QTc intervalMeasurements are obtained at baseline and every 60 minutes after study drink consumption over 4 hoursMaximum change in QTc interval from baseline in each of 2 arm
Central systolic blood pressureMeasurements are obtained at baseline and every 60 minutes after study drink consumption over 4 hoursMaximum change in central systolic blood pressure from baseline in each of 2 arm

Secondary

MeasureTime frameDescription
QRS durationMeasurements are obtained at baseline and every 60 minutes after study drink consumption over 4 hoursMaximum change in QRS duration from baseline in each of 2 arm
Heart rateMeasurements are obtained at baseline and every 60 minutes after study drink consumption over 4 hoursMaximum change in heart rate from baseline in each of 2 arm
QT intervalMeasurements are obtained at baseline and every 60 minutes after study drink consumption over 4 hoursMaximum change in QT interval from baseline in each of 2 arm
Peripheral systolic and diastolic blood pressureMeasurements are obtained at baseline and every 60 minutes after study drink consumption over 4 hoursMaximum change in peripheral systolic and diastolic blood pressures in each of 2 arm
Augmentation indexMeasurements are obtained at baseline and every 60 minutes after study drink consumption over 4 hoursMaximum change in augmentation index from baseline in each of 2 arm
Central diastolic blood pressureMeasurements are obtained at baseline and every 60 minutes after study drink consumption over 4 hoursMaximum change in central diastolic blood pressure from baseline in each of 2 arm
PR intervalMeasurements are obtained at baseline and every 60 minutes after study drink consumption over 4 hoursMaximum change in PR interval from baseline in each of 2 arm

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026